Cancer Vaccine Strategy Using SNAs
In this video, Professor Chad Mirkin from Northwestern University explains how spiracle nucleic acids (SNAs) can be used to create cancer vaccines. If someone has breast cancer, they begin to have circulating tumors. Probing these cells can lead to diagnostic for diseases and also lead to the development of personalized medicine. SNAs can be selectively engaged to activate the immune system, trigger immune response, and thereby kill cancer cells. By combining SNAs with existing drugs called checkpoint inhibitors, we can create therapeutics that can tweak the immune system and destroy cancer-causing cells.
Run Time – 3:57min